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The rate of decline of pulmonary function in CF has been reported to be constant,
however linear decay is a simpliﬁcation and more complex models are needed to
describe FEV1(% pred.) We have developed a mathematical model to describe
FEV1(% pred.) changes in time.
We used the data of the CF Center in Verona (Italy) where neonatal screening
for cystic ﬁbrosis was introduced in 1973 and became compulsory in the early
1980s. We analyzed 11281 values of FEV1(% pred.) of 242 patients diagnosed by
neonatal screening and followed since birth. In order to be included in the analysis
a patients should have performed at least 6 spirometry measurements since the age
of 7 yrs. The observation period lasted between November 1979 and April 2007.
The model was chosen using the Akaike information criterion [1]. It indicated the
second-order mixed-effects model, with regard to both the average evolution and
the variance structure. Multi-slope models were also applied to the data. A non-
linear method was used to determine the age at which let the slope change. The
Akaike information criterion suggests the use of the three slopes model (r2: 0.88;
AIC value: 83518.44), which was so used as a basis for further analysis.
The model allowed to reliably forecast the evolution of FEV1(% pred.) since the
age of thirteen.
This model should now be validated in other centers and if so it could be used
to identify early patients at risk, to study period effects on disease severity and
progression and the inﬂuence of risk factors or treatments on pulmonary disease in
CF.
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Exercise capacity is one of the prognosis factors in cystic ﬁbrosis (CF). Maximal
oxygen consumption (VO2peak) quantiﬁes this aerobic capacity. It is therefore
relevant to use a low cost and practical tool to estimate this prognosis data.
We propose to test a new self-administered questionnaire on daily physical activity
(QDPA) estimating VO2peak and daily energy expenditure (DEE). DEE was
calculated by multiplying time spent in each activity by its energy cost corrected
for weight, age, sex, autonomy and the total was calculated over 24 h. This tool
divided DEE into three levels of intensity: <3 MET, 3−5 MET and >5 MET. These
data were compared with VO2peak obtained from a maximal modiﬁed shuttle test
(MST).
18 adults CF patients with stable disease completed the study (10 females,
age=28±8.7 yrs, FEV1=55.6±26% of predicted, BMI=21±3.4kg/m2). All except
three had pancreatic insufﬁciency. Two third had chronic pseudomonas colonisation.
DEE reached 10200.5±3170.2 kJ/24 h and was signiﬁcantly correlated with
VO2peak (L/min) measured during the MST (r = 0.796, p 0.001). It was also cor-
related with BMI (r = 0.808), FVC% (r = 0.809) and professional activity (r = 0.493).
No correlation was found with age, sex, bacteriological status, or diabetes. DEE
estimated by QDPA was determined by both intensity and type of activity.
This questionnaire seemed relevant to estimate maximal exercise capacity in CF
patients. It also added qualitative and quantitative information on DEE. It can be a
simple and interesting tool if larger studies conﬁrm our results.
233 Assessment of respiratory compliance in infants with cystic
ﬁbrosis
N. Pillarisetti1, B. Linnane1, H. Sowerbutts2, B. Skoric1, G. Hall3,
S. Ranganathan1,4. 1Respiratory Medicine, Royal Children’s Hospital, Melbourne,
VIC, Australia; 2University of Oxford Medical School, Oxford, United Kingdom;
3Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA,
Australia; 4Brighton and Sussex Medical School, Brighton, United Kingdom
Aim: To estimate respiratory compliance in infants with CF at two inﬂation
pressures and to compare measurements in individuals over time. To evaluate the
association between compliance and measures of forced expiration.
Methods: Respiratory compliance was measured as the change in lung volume
at inﬂation pressures of 20 and 30cm of water during passive inﬂations. Raised
volume(RVRTC 30) parameters such as FVC, FEV 0.5 and MEF 25 were measured
and z scores calculated based on published reference equations. Measurements were
repeated 6 to 12 months later.
Results: 20 infants were tested at median (range) ages of 21.8(11.5−75.7) and
59.7(46.8–114.4) weeks at the ﬁrst and second test respectively. Mean (SD)
respiratory compliance at 20 and 30 cm inﬂation pressures was 9.5(3.5)and 10.6
(4.3)ml/cm H20 at the ﬁrst test and 11.4(3.8) and 12.7 (3.9)ml/cm H20 at the second
test respectively. While there was no statistically signiﬁcant change in respiratory
compliance between the tests (at 30 cm of water p = 0.09), there was a statistically
signiﬁcant decrease in FVC, FEV 0.5 and MEF 25 z scores over this time. There was
no association between respiratory compliance at each test, or change in compliance
over time, with gender, airway infection and measurements from the RVRTC.
Conclusions: Estimated respiratory compliance at 20 and 30cm were similar sug-
gesting that measurements were made at similar parts of the pressure volume curve
in infants with CF. Early CF lung disease is characterised by airway obstruction
which is not associated with a change in respiratory compliance.
Supported by: USCFF, NHMRC, RCCFRT.
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Management of CF respiratory symptoms includes lung function testing (LFT)
and, in particular, the early identiﬁcation and treatment of small airways disease.
Spirometry, a commonly used LFT, requires a forced expiration and is more suitable
for children >5 years old. The impulse oscillation system (IOS) measures airway
resistance, impedance and reactance and requires only quiet tidal breathing. Work
on IOS has been published in pre-school children with asthma but there is a paucity
of data in children with CF.
Currently mid-expiratory ﬂow (MEF) parameters are used to asses the calibre of
the small airways, an area of concern in CF children. We hypothesized that MEF
and IOS measurements related to small airways would correlate well, suggesting
IOS to be a suitable diagnostic technique in CF children unable to appropriately
undertake spirometry.
Data from 21 consecutive CF patients (8 female, 13 male, ages 6.0−15.9 yr)
was analysed. Comparison of spirometry and IOS parameters, Spearman’s Rank
Correlation, resulted in r values between −0.59 and −0.94 (p< 0.01, in all cases).
MEF75−25 correlated against X5, reactance at 5Hz, the primary parameter of small
airway disease, had r = −0.84. There was no linear relationship between MEF75−25
and R5-R20Hz, difference in resistance at 5 and 20Hz and the secondary parameter
of small airways. The highest r values were MEF75 against Z5, impedance of the
total respiratory system at 5Hz, and against R5, r = −0.94 and −0.92 respectively.
IOS may be a suitable alternative or additional test for assessing small airway
function in young CF children. However, the complex relationships between the
two measurements remain to be evaluated and may reﬂect differences in small
airways function during quiet tidal breathing and forced expiration.
